47 studies found for:    physical | urticaria
Show Display Options
Rank Status Study
21 Terminated Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Conditions: Atopic Dermatitis;   Psoriasis;   Alopecia;   Mycosis Fungoides;   Urticaria;   Dermatoses;   Stretch Marks
Intervention: Procedure: UVA1 and UVB Irradiation
22 Completed Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
23 Completed A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
Conditions: Urticaria;   Chronic Idiopathic Urticaria
Intervention: Drug: desloratadine
24 Not yet recruiting OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
Condition: Chonic Spontaneous Urticaria
Intervention: Drug: omalizumab
25 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
26 Completed Study on Mastocytosis for Rupatadine Treatment
Condition: Mastocytosis
Intervention: Drug: Rupatadin
27 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
28 Completed Cause and Natural Course of Pediatric-Onset Mastocytosis
Condition: Mastocytosis
Intervention:
29 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis
Intervention:
30 Completed Stem Cell Transplantation to Treat Systemic Mastocytosis
Condition: Mastocytosis
Intervention: Procedure: Stem cell transplantation
31 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
32 Recruiting Study of Mast Cell Precursors
Condition: Mastocytosis
Intervention:
33 Unknown  Molecular Mechanisms and Diagnosis of Mastocytosis
Condition: Mastocytosis
Intervention:
34 Completed Characteristics of Mast Cells in Mastocytosis
Condition: Mastocytosis
Intervention:
35 Terminated Effectiveness of Bradykinin Receptor Blocker at Reducing Swelling Associated With Angiotensin Converting Enzyme (ACE) Inhibitor-Associated Angioedema
Condition: Angioneurotic Edema
Interventions: Drug: HOE-140;   Other: Placebo
36 Active, not recruiting A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161
Condition: Hereditary Angioedema
Intervention: Drug: BCX4161
37 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
38 Completed A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
39 Unknown  Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
40 Not yet recruiting Hereditary AngioEdema, Neurobiology and Psychopathology
Conditions: Hereditary AngioEdema;   Anxiety;   Depression
Intervention: Other: Clinical and psychopathological assessment of HAE patients

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results
Indicates status has not been verified in more than two years